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Abstract
Background: Incarcerated individuals suffer disproportionately from the health effects of tobacco smoking due to
the high smoking prevalence in this population. In addition there is an over-representation of ethnic and racial
minorities, impoverished individuals, and those with mental health and drug addictions in prisons. Increasingly,
prisons across the U.S. are becoming smoke free. However, relapse to smoking is common upon release from
prison, approaching 90% within a few weeks. No evidence based treatments currently exist to assist individuals to
remain abstinent after a period of prolonged, forced abstinence.
Methods/Design: This paper describes the design and rationale of a randomized clinical trial to enhance smoking
abstinence rates among individuals following release from a tobacco free prison. The intervention is six weekly
sessions of motivational interviewing and cognitive behavioral therapy initiated approximately six weeks prior to
release from prison. The control group views six time matched videos weekly starting about six weeks prior to
release. Assessments take place in-person 3 weeks after release and then for non-smokers every 3 months up to 12
months. Smoking status is confirmed by urine cotinine.
Discussion: Effective interventions are greatly needed to assist these individuals to remain smoke free and reduce
health disparities among this socially and economically challenged group.
Trial Registration: NCT01122589
Background
Tobacco use contributes to over 400,000 deaths
annually [1]. It is a major contributor to both cancer and
heart disease risk, and is the leading cause of preventable
morbidity, mortality and health expense in the United
States [2]. There is an estimated $157 billion in annual
health related and economic costs [2]. Quitting smoking
reduces the risks of developing smoking related illnesses
as well as the morbidity and mortality associated with
these illnesses.
In 2009 approximately 46.6 million American adults
smoked, an overall prevalence of 20.6% [3]. The prevalence
of smoking is much higher among incarcerated popula-
tions. Across the U.S. tobacco use among prisoners is
approximately three times that of the general popula-
tion, [4] and in some areas is even higher. For example
approximately 80% of the women incarcerated in RI
smoked prior to incarceration [5]. Moreover, incarcerated
populations suffer disproportionately from health dispari-
ties due to tobacco associated illnesses, as minorities,
poor, mentally ill and illicit substance using individuals are
all overrepresented in correctional facilities. With approxi-
mately 9 million Americans passing through correctional
institutions annually and an average daily population of
over 2 million, there are multiple opportunities to address
the smoking cessation needs of this high risk and under-
served population [6].
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quences of second hand smoke, correctional facilities are
increasingly becoming tobacco free. The Rhode Island
Department of Corrections (RI DOC) has been tobacco
free since February 2003, with no tobacco products
allowed anywhere on grounds by inmates or staff. How-
ever, the majority of inmates return to smoking as soon
as they are released back into the community [7].
Few data are available on relapse prevention interven-
tions delivered after extended periods of forced tobacco
abstinence. Medications for smoking cessation are unlikely
to be effective as people in this situation have already com-
pleted nicotine withdrawal. One approach that has
demonstrated efficacy and effectiveness for assisting in
smoking cessation and maintenance is cognitive behavioral
therapy (CBT) [8,9]. This approach teaches skills that
enhance the individual’s ability to cope with challenges
and remain smoke free. However, CBT is limited in its
applicability to the prison setting, in that some skills
(delaying time between cigarettes, self-monitoring smok-
ing patterns) cannot be practiced in a smoke free facility.
Moreover, skills-based approaches may be moot for indivi-
duals who may not be motivated to learn and implement
skills. Thus, we chose to enhance a CBT-based interven-
tion with additional sessions of Motivational Interviewing
(MI), to enhance interest in remaining smoke free so that
skills will be learned and utilized post-release from incar-
ceration [10,11]. This study is designed to evaluate the
effects of an Intensive Behavioral Intervention (IBI, which
combines MI+CBT) on post-release smoking abstinence
rates as well as motivation to remain abstinent among a
population of incarcerated men and women who had
smoked prior to incarceration and are scheduled to be
released.
Methods/Design
Design
The study design is a randomized, controlled trial com-
paring two groups: 1) six sessions of individual MI and
CBT counseling (IBI) and 2) six general wellness videos
(Control). Participants are recruited and randomly
assigned to either the IBI or time-equivalent control con-
dition eight weeks prior to their release date from a
smoke free prison. Those randomized to IBI will receive
t w oM Ia n df o u rC B Ts e s s i o n si np r i s o n( 1s e s s i o np e r
week) as well as two brief (approximately 15 minutes) tel-
ephone counseling sessions after their release. Assess-
ments are conducted in person at baseline, by phone 24
hours and 7 days after release, and in person at the final
three week post-release follow up. This study is approved
by the Memorial Hospital of RI Institutional Review
Board, the Office for Human Research Protections and
the Medical Research Advisory Group at the RI DOC.
Sample Size Considerations
Sample size was selected to permit analysis of the pri-
mary research questions at an alpha of .05 one-tailed and
a power level of at least .80. The primary dependent vari-
able used in the power analysis is point-prevalence absti-
nence (self-report of 7-day abstinence confirmed by
cotinine, per Hughes) [12]. Based on three Cochrane
Database of Systematic Reviews [13-15] and a very exten-
sive meta-analysis of approximately 8,700 studies that
addressed assessment and treatment of tobacco depen-
dence [13,16] we used 23% abstinence as the estimate of
abstinence in the intervention Group. We used a conser-
vative estimate of abstinence of 14% for the control
group for a sample size requirement of 235 per group.
We planned for an interim analysis after 200 participants
were recruited as one study found that 97% of inmates
return to tobacco use with no treatment by six months
following release [17].
Participant recruitment
Potential participants are recruited by Research Assis-
tants (RAs) in the housing units at the RI DOC sentenced
women’s facilities and men’s medium security facility.
RAs will identify themselves as research staff (not RI
DOC staff) and inform potential participants that study
participation is completely voluntary and does not affect
any privileges at the facility including probation or parole
status. The planning and research unit of the RI DOC
provides a weekly list of all inmates scheduled to be
released. RAs review the list for all inmates scheduled to
be released within the next eight weeks and call them
individually to a private area to be informed about the
study. Individuals who are interested in participating are
screened for eligibility. Both men and women are eligible
to participate if they are 18 years or older, smoked at
least ten cigarettes per day prior to incarceration, speak
English, and are scheduled to be released within eight
weeks of study enrollment. Eligible individuals are given
a consent form to review and the RA explains the study.
If eligible and willing to participate in the study, the
informed consent process is completed (study explained,
consent form read to the individual, questions answered
and forms signed). The RA provides all participants with
an American Heart Association smoking cessation
pamphlet, a list of community resources and study con-
tact information. A 60 minute computer assisted ques-
tionnaire is administered to all participants at baseline,
prior to any intervention activities.
Procedures
After the baseline assessment is completed participants
are randomly assigned to either IBI or Control. Rando-
mization is stratified by gender, the amount of cigarettes
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than 20 cigarettes a day vs. 20 or more cigarettes a day),
and post release smoking plans. Plans to remain tobacco
abstinent are assessed with a single question “Which
ONE statement BEST describes your plans for smoking?“
with low levels of planning to remain abstinent includ-
ing responses “Ip l a nt os m o k ew h e nIg e to u to fh e r e
and I never plan to quit” to “I will probably smoke
when I get out of here”. High levels of planning to
remain abstinent include responses ranging from
“I probably won’t smoke when I get out of here” to
“I have made plans to not smoke when I get out and I
will never smoke again.” Randomization is concealed
and takes place independently of the RAs. IBI counsel-
ing and Control video sessions are scheduled weekly,
however, if a release date is moved forward then the fre-
quency of sessions or videos is increased such that all
six are completed prior to the participant’s release.
Interventions
IBI
Intervention sessions are conducted over an approxi-
mately six week period prior to release. Participants
randomized to IBI receive six counseling sessions, while
still incarcerated. In sessions one and six the participant
receives MI counseling and in sessions 2-5 the partici-
pants receive CBT counseling. Sessions are delivered by
RAs who have undergone intensive training with experts
in MI and CBT. Supervision is conducted twice monthly
to ensure continued adherence and competence with the
MI and CBT protocols. Sessions last between 30 and 60
minutes depending on the needs of the participants. The
research counselors’ therapeutic style and protocol are
based on the principles of MI, with a focus on empathy,
not arguing, developing discrepancy, self-efficacy, and
personal choice[18]. Sections of the MI include develop-
ing rapport, exploration of motivation (pros and cons),
personalized assessment feedback, and establishing goals.
The final MI session mirrors the first session, but adds
additional emphasis on re-assessing and increasing moti-
vation to be smoke-free with release date approaching.
With participant permission, a quit plan is developed
with post-release goals, reasons for goals, specific actions
and supports, and possible barriers to goals and solu-
tions. Participants who do not wish to develop goals are
thanked for their time, counselors acknowledge that only
the participant is able to make a decision regarding his/
her commitment to smoking abstinence, and these parti-
cipants are invited to use the information provided in the
counseling sessions in the future if they would like.
The CBT sessions are delivered using a standardized
program manual and work sheets to ensure consistent
delivery of content. CBT sessions teach smokers to recog-
nize specific environmental and affective events (“triggers“)
that occur prior to smoking and to identify behavioral and
cognitive strategies to cope with these triggers. Partici-
pants are provided with information on numerous strate-
gies to assist with maintaining smoking abstinence and
renewing cessation in case of relapse. These strategies
include avoiding trigger situations (e.g., temporarily avoid-
ing drinking coffee), altering these situations (e.g., drinking
juice instead of coffee), and engaging in an alternative
behavior (e.g., going for a walk, or practicing deep breath-
ing instead of smoking). Additional brief telephone ses-
sions are conducted at approximately 24 hours and 7 days
after the individual’s release. These sessions included ele-
ments of both MI and CBT in an effort to re-evaluate and
establish motivation and use of skills after release.
Control
Individuals randomized to the Control condition watched
a series of videos weekly to match the IBI condition on
time spent and frequency of contact. The control videos
are between 30 and 60 minutes long and include a variety
of health related topics (1. “Managing Chronic Pain,” 2.
“Managing Migraines,” 3. “Managing Respiratory Infec-
tions,” 4. & 5. “Super Size Me,” 6. “Know your Num-
bers”). To maintain frequency and duration of contact,
telephone calls are scheduled for approximately 24 hours
and 7 days after release, and are used assessment of
smoking status only (no intervention is administered).
Quality Control
All intervention sessions are audio recorded and a random
20% are reviewed and scored for intervention content. The
MI sessions are scored using the MITI 3.1 [19] for MI
compliance, and CBT sessions are independently scored to
ensure scheduled content is adequately covered in each
session. RAs receive two group supervision sessions a
month; one for CBT and one for MI.
Measures
Participants complete full assessments at baseline and at
three week follow up, and brief assessments of smoking
status at 24 hours and 7 days post-release. Audio Compu-
ter-Assisted Self-Interviews (A-CASI) are used to collect
information at baseline and the week three follow up.
With A-CASI, survey respondents listen to questions on
headphones, see them on a computer screen, and answer
them directly on the computer. The RA is available to
assist in case of technical difficulties and to answer partici-
pant questions. The full assessment battery takes about 60
minutes to complete and includes demographic variables,
smoking history and nicotine dependence assessed by the
Fagerstrom Test for Nicotine Dependence [20]. Smoking
decisional balance is assessed with The Decisional Balance
Scale (short form) a six item measure of the pros and cons
of smoking [21]. Smoking cessation self-efficacy is assessed
using the nine-item short form of the Smoking Situations
Confidence questionnaire [22]. Motivation to remain
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der, [23] modified to account for the smoke free environ-
ment. The four-item Perceived Stress Scale (PSS) [24] is
used to document subjective increases in stress. Substance
use is evaluated with the Addiction Severity Index
(ASI), [25,26] and depressive symptoms with the 10-item
Center for Epidemiologic Studies Depression Scale CES-
D [27]. Reviews of prison records are done to obtain the
number of days between incarceration and release as well
as the number of prior incarcerations. At the three week
follow up a urine sample is obtained to test for Cotinine,
THC (marijuana), cocaine, PCP, opiates, methampheta-
mines, methadone, amphetamines, barbiturates, benzodia-
zepines and MDMA ("ecstasy”).
A brief questionnaire is administered to assess for
changes in motivation to quit, stress and depression. A
detailed timeline follow back (TLFB) of the time since
release is administered to assess tobacco use as well as
drug and alcohol use, living situation and a detailed history
the situation leading to the first cigarette if a relapse
occurs. For participants who are smoke free at three
weeks, monthly phone surveys are completed to assess
continuous abstinence and in-person follow ups are sched-
uled for three and six months post-release to biologically
confirm the smoking status.
Outcomes
The primary outcomes of this study are smoking absti-
nence rates post release as well as number of days to first
cigarette after release. Seven day point-prevalence absti-
nence will be determined by combining self-reported
tobacco use over the prior seven days and urine cotinine
assays (below 200 ng/ml versus 200 or above). Participants
with self-reported abstinence and cotinine levels below the
cut-off will be classified as abstinent. Participants lost to
follow-up will be considered non-abstinent. A secondary
analysis will examine the effect of length of forced absti-
nence on quit rates.
Time plan
The development of this program began in August of
2009 and was finished in February 2010. Participant
recruitment started in March 2010 and is ongoing with
plans to complete the study in August 2011.
Planned Analyses
Overview
All analyses will be based on intent to treat; participants
who receive their assignment to condition will be used in
analyses [28]. The primary hypothesis of the study will be
tested using generalized estimating equations (GEE) [29].
We will test whether IBI will result in significantly more
seven-day point-prevalence compared to Control. We
will also analyze three secondary smoking variables:
(1) percent days abstinent post release; (2) average num-
ber of cigarettes/day; and (3) number of days to first
cigarette after release. We will use mixed effects models
for the secondary smoking outcomes and will covary the
same variables assessed at baseline. We will also examine
substance use outcomes by calculating the percents days
used other drugs and alcohol from the ASI. We will test
the effects of varying lengths of forced abstinence (incar-
ceration) on tobacco quit rates (seven-day point preva-
lence) using GEE. Our hypothesis is that, regardless of
intervention condition, longer incarcerations will be asso-
ciated with greater quit rates at 3 weeks post release. For
this analysis the length of forced abstinence (in days) cal-
culated from first date of incarceration to date of release
will be used to predict seven-day point-prevalence.
Further analyses will examine the effects of IBI on
smoking outcomes is attributable to potential modera-
tors and if the relationship between IBI and smoking
outcome is mediated by relevant variables [30,31] We
will test the following potential mediators: education,
race/ethnicity, motivation to quit smoking and smoking
related illnesses.
In terms of moderators, we expect that IBI will have an
especially strong positive effect on smoking outcomes,
relative to Control, in the presence of older age, high
levels of stress, living with a smoker, homelessness,
depression/anxiety disorders, male gender, nicotine
dependence, lower SES and social support.
Discussion
If this intervention is efficacious, it can address the
important issue of how to maintain smoking cessation
after forced abstinence due to incarceration. Once
released from a smoke free environment (incarceration,
basic military training, substance abuse treatment or psy-
chiatric facility) the vast majority of smokers immediately
start smoking again [7,32-34]. Hence, despite forced
abstinence many smokers need interventions to decrease
relapse post release. As described above, CBT has
demonstrated efficacy/effectiveness; however, skills-based
interventions may be less effective for persons unmoti-
vated to implement them. The current literature does not
address a combined approach to both a) enhance interest
in maintaining cessation and b) learn and implement
skills during forced abstinence while incarcerated. This
study addresses this gap in the knowledge base. In addi-
tion, given the racial/ethnic diversity often found in these
settings, it is important to study interventions that may
be suitable to this diverse population.
This study is an initial investigation of the efficacy of
combined MI/CBT for smoking abstinence after release.
While prior studies used longer follow-ups, we chose an
abbreviated follow-up because relapse to smoking is
rapid after release and this is the first intervention study
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outcomes of this study will reveal if MI/CBT has the
potential to improve smoking cessation rates after
release from prison and will provide information to
adjust the intervention if needed. The design chosen for
this study will allow us to explore potential mediators of
the intervention’s efficacy so that we may better under-
stand the mechanism(s) by which this intervention may
impact maintenance of smoking cessation.
Innovative treatments are needed that address enhan-
cing interest in and skills for maintaining a smoke-free
life-style after forced abstinence due to incarceration. This
is a highly underserved population in great need. MI has
been associated with good outcomes in racially/ethnically
diverse samples, [35,36] which is significant for prison set-
tings that reflect high proportions of ethnic and racial
minorities. A motivationally based intervention revealed
that for smokers not motivated to quit, the intervention
led to an odds ratio of quitting of 1.79 over controls and
even higher (4.9) for ethnic minorities [32]. Similarly, CBT
also demonstrates good intervention effects for racial and
ethnic minorities [8,37,38]. Although some meta-analyses
have suggested that the effects of MI may not be robust
for smoking, [39] others have argued against this [36,40].
However, our use of MI is to enhance interest in change
(i.e., maintaining cessation) and in engaging with addi-
tional treatment, and both uses have demonstrated effi-
cacy [35,41-43]. Therefore, MI+CBT may prove to be a
more efficacious treatment for maintaining smoking absti-
nence after release from incarceration than either treat-
ment alone. Importantly, this study will afford the
opportunity for follow-up after release from incarceration,
which is rarely or ever found in the literature with respect
to smoking behaviors.
Incarcerated people have higher smoking prevalence
than the general population and suffer disproportionately
from the health effects of tobacco smoking due over-
representation of ethnic and racial minorities, impover-
ished individuals, and those with mental health and drug
addictions [17,44-48]. The incarcerated setting provides a
unique opportunity to intervene with this population prior
to their release back into the community. Provision of an
individually-tailored intervention to this particular popula-
tion in this specific setting represents a highly innovative
and extremely important effort to reach a vulnerable
population of smokers.
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